Healthways Inc. (NASDAQ:HWAY)’s share price traded down 2.1% on Tuesday . The company traded as low as $23.11 and last traded at $23.31, with a volume of 330,080 shares trading hands. The stock had previously closed at $23.82.

A number of equities analysts have weighed in on the company. Barrington Research reiterated a “buy” rating on shares of Healthways in a research note on Saturday, April 30th. Piper Jaffray Cos. lifted their price objective on Healthways from $15.00 to $25.50 and gave the company an “overweight” rating in a research note on Wednesday, August 10th. Zacks Investment Research upgraded Healthways from a “hold” rating to a “buy” rating and set a $20.00 price objective for the company in a research note on Monday, August 8th. Oppenheimer Holdings Inc. lowered Healthways from an “outperform” rating to a “market perform” rating in a research note on Friday. Finally, Jefferies Group lifted their price objective on Healthways from $13.00 to $18.50 and gave the company a “hold” rating in a research note on Thursday, August 4th. One research analyst has rated the stock with a sell rating, one has given a hold rating and five have given a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $19.71.

The firm’s 50-day moving average is $14.42 and its 200 day moving average is $12.12. The firm’s market capitalization is $866.65 million.

Healthways (NASDAQ:HWAY) last released its quarterly earnings data on Tuesday, August 9th. The company reported $0.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.53. During the same quarter in the prior year, the company earned $0.11 EPS. The company earned $125 million during the quarter, compared to analyst estimates of $186.88 million. The business’s revenue was up 10.2% on a year-over-year basis. Equities research analysts forecast that Healthways Inc. will post $0.43 earnings per share for the current year.

An institutional investor recently raised its position in Healthways stock. BNP Paribas Arbitrage SA increased its stake in shares of Healthways Inc. (NASDAQ:HWAY) by 37.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 80,127 shares of the company’s stock after buying an additional 21,702 shares during the period. BNP Paribas Arbitrage SA owned approximately 0.22% of Healthways worth $1,031,000 at the end of the most recent reporting period.

Healthways, Inc (Healthways) provides network delivered solutions and population health management services that are designed to help people manage their wellbeing, thereby managing their health and productivity, and their health-related costs. The Company operates in the domestic and international segments, which are collectively known as the well-being improvement services segment.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.